Developer docs
API playgroundTry for free, no card

Search company profiles

Sanexus

Full company profile

uuid02bftl5

Namestring
Sanexus
Legal namestring
Sanexus, Inc.
Websiteurl
sanexus.ai
Company typeenum
Private
Founded yearint
2025
Descriptiontext

Sanexus is a privately held, founder-led digital health company headquartered in New York that has developed Asta, an agentic AI-powered platform for supportive oncology care. Asta delivers adaptive, context-aware emotional, educational, logistical, and lifestyle support to cancer patients between clinical visits; it administers validated patient-reported outcome instruments (PRO-CTCAE, EORTC QLQ-C30), tracks symptoms and quality-of-life continuously, and escalates to the clinical team when safety thresholds are met. The platform connects to electronic health records — including Epic via MyChart — through SMART on FHIR standards-based APIs, and runs on AWS infrastructure with Amazon Bedrock providing AI inference for its conversational agent. Asta operates as a Business Associate under HIPAA-compliant controls including encryption in transit, access controls, audit logging, and regular security reviews.

The company sells Asta on a B2B subscription-based SaaS model under Terms of Service effective May 26, 2026, using a direct enterprise sales motion with Request a Demo, Pilot Consultation, and Get in Touch conversion points. Pricing is not publicly disclosed and is quote-based. Three customer segments are targeted: oncology providers seeking to extend supportive care reach without adding staff; life sciences companies running oncology clinical trials that need real-time participant support, PRO capture, adherence improvement, and earlier safety signal detection; and academic research institutions and grant-funded teams (including NIH and ARPA-H applicants) needing configurable assessment protocols and longitudinal data capture for digital health intervention research. Research collaborations with Cornell Tech and the Jacobs Technion-Cornell Institute support the academic vertical.

Sanexus was founded by Malwina Lewicka, PhD (Co-Founder & CEO, health psychologist with a postdoctoral fellowship in Psycho-Oncology at Memorial Sloan Kettering Cancer Center) and Michael Federico (Co-Founder & CTO, software engineer with a BS in Computer Science from the University of Notre Dame and conversational AI experience in financial services). Stated headcount is 1–10 with only the two founders confirmed; no funding rounds, paying customers, or revenue figures are disclosed in the available sources. The company is incorporated in New York and operates as Sanexus, Inc.

Short descriptiontext

Sanexus develops Asta, an agentic AI-powered digital health platform delivering adaptive supportive care, symptom monitoring, and validated PRO capture (PRO-CTCAE, EORTC QLQ-C30) for oncology patients between clinical visits. It sells B2B subscriptions to cancer centers, pharma clinical trial sponsors, and academic research institutions.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
1–10
akta.pro rankint
HeadquartersNew York, United States
HQ citystring
New York
HQ countrystring
United States
HQ regionstring
North America
Markets served

Serves global market

Offices1 record

Each record includes

City, Country, Type, Description, Source

Keyword5 values
supportive oncology care, digital health platform, patient-reported outcomes, clinical trial technology, conversational AI healthcare
Industry4 codes
PRIMARYHLALAFAD
Oncology Remote Symptom Monitoring & Care Navigation
Healthcare & Life Sciences/Telehealth Platforms/Chronic Care & Remote Patient Monitoring (RPM) Platforms
SECONDARYHLALAGAH
Oncology Telemedicine Platforms
Healthcare & Life Sciences/Telehealth Platforms/Specialty Telemedicine Platforms (e.g., dermatology, cardiology, neurology)
SECONDARYHLAGAJAM
Clinical Trial Informatics (EDC/CTMS/eCOA/eTMF)
Healthcare & Life Sciences/Life Science Tools & Services (CRO/CDMO/Lab Services)/Life Science Software & Informatics (LIMS/ELN/Bioinformatics)
SECONDARYHLALABAJ
Patient Engagement, Education & Messaging Platforms (portal/CRM integrated)
Healthcare & Life Sciences/Telehealth Platforms/Provider-Integrated Virtual Care Platforms (Health Systems/Clinics)
NAICS code3 codes
  • Computer Systems Design Services541512
  • Custom Computer Programming Services541511
  • Computer Systems Design and Related Services54151
SIC code3 codes
  • Services-Health Services8000
  • Services-Prepackaged Software7372
  • Services-Computer Integrated Systems Design7373
Product category
Digital Health / Supportive Oncology Care Software
Social media profiles1 record
GTM motion1 record

Each record includes

Type, Description, Source

Revenue model1 record
1Subscription-based SaaS
TypeSubscription Recurring
Description

B2B subscription model for oncology providers, life sciences companies, and research institutions. Terms of Service references 'Subscription and Fees' section indicating recurring revenue. Pricing not publicly disclosed; likely tiered by provider size or patient volume.

sanexus.ai
Marketing channels1 record

Each record includes

Title, Type, Stage, Description, Source

Distribution channels1 record

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components5 values
Technology or R&D, Personnel, Infrastructure, Marketing or Sales, Operations
GTM typeB2B
B2B
Offering typeSoftware
Software
Brand1 record
1Asta
Description

AI-powered supportive oncology care platform that delivers emotional, educational, logistical, and lifestyle support to cancer patients between clinical visits.

sanexus.ai
Core offering1 text field

Sanexus develops Asta, an agentic AI-powered digital healthcare platform that delivers adaptive, real-time emotional, educational, logistical, and lifestyle support to cancer patients between clinical visits. The platform is sold as a B2B subscription to oncology providers, life sciences companies running oncology clinical trials, and academic research institutions, and combines conversational AI, validated PRO instrument assessments (PRO-CTCAE, EORTC QLQ-C30), early adverse event detection with clinical escalation, and SMART on FHIR EHR integration with Epic.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 3 values shown
  • 80%+ of cancer patients report unmet supportive care needs, representing the addressable market problem Asta addresses
+2 more records
Product overview1 text field

Sanexus offers a single unified platform product called Asta — an AI-powered digital healthcare companion for supportive oncology care. The platform extends care between clinical encounters through adaptive AI-driven conversations that deliver personalized support, symptom tracking, validated assessments (PRO-CTCAE, EORTC QLQ-C30), and clinical escalation when safety thresholds are met. Asta serves three segments: oncology providers, life sciences companies (clinical trials), and research institutions.

Product and service1 record
1Asta
CategorySupportive Oncology Care Software
Description

Agentic AI-powered digital healthcare platform for supportive oncology care. Delivers adaptive, real-time emotional, educational, logistical, and lifestyle support to cancer patients between clinical visits. Features context-aware intelligence, proactive personalized information delivery, PRO instrument integration (PRO-CTCAE, EORTC QLQ-C30), early adverse event detection with clinical escalation, and SMART on FHIR integration with Epic/MyChart. Sold as a B2B subscription to oncology providers, life sciences companies running oncology clinical trials, and academic research institutions.

Scale indicator3 records

Each record includes

Type, Value, Description, Source

Partnership3 partners
Strategic tierCoreTypeStrategic or Co-development Partner
Description

Research collaboration with Cornell Tech on digital health technology development. Cornell Tech is a graduate-level institution founded by Technion-Israel Institute of Technology and Cornell University, focused on technology and entrepreneurship.

Strategic tierCoreTypeStrategic or Co-development Partner
Description

Academic partnership with the Jacobs Technion-Cornell Institute at Cornell Tech for advancing digital health interventions research and development.

Strategic tierCoreTypeTechnology or Integration
Description

EHR integration partnership enabling patients to connect Asta to their Epic MyChart account. Uses SMART on FHIR standards-based APIs to exchange demographic data, conditions, medications, lab results, vital signs, allergies, procedures, and care plans.

Recent move6 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight5 records

Each record includes

Type, Description

Peers10 records
1Pack Health
TypeDirect peer
Description

Digital health coaching platform providing condition-specific (including oncology) one-on-one coaching and structured support between visits. Comparable in serving the same between-visit supportive care gap and selling into the same provider and pharma channels.

TypeEmerging player
Description

Healthcare-focused LLM company building agentic AI agents for patient-facing interactions across multiple clinical use cases. Comparable as a peer in the agentic-AI-for-healthcare category, though Hippocratic targets a broader set of conditions and is better funded.

TypeDirect peer
Description

Digital care platform delivering structured, episode-based patient engagement and PRO capture across musculoskeletal and chronic conditions. Comparable in using validated PROs, EHR integration, and enterprise sales to provider systems, though focused on orthopedics rather than oncology.

TypeEmerging player
Description

AI-powered oncology patient support and care companion app delivering personalized education, symptom tracking, and emotional support between visits. Comparable as an AI-native oncology supportive care platform targeting similar patient/provider use cases, though likely smaller and earlier stage.

TypeDirect peer
Description

Digital oncology platform providing personalized supportive care, symptom management, and care navigation to cancer patients between visits. Most directly comparable peer because it targets the same buyer (oncology providers), the same patient population, and the same unmet need (between-visit supportive care).

TypeDirect peer
Description

Oncology patient engagement platform serving cancer centers with symptom monitoring, distress screening, and care management tools. Comparable because it sells to the same oncology provider buyers and operates in the same distress screening / supportive care gap that Asta targets.

TypeBroad incumbent
Description

Roche-owned oncology technology and real-world data platform with deep penetration across US cancer centers, EHR integration, and life sciences trial services. Comparable as a much larger incumbent competing for the same oncology provider and pharma budgets, though it focuses more on data and research enablement than between-visit patient support.

8Tempus AI
TypeBroad incumbent
Description

AI-powered precision medicine company with a large oncology footprint spanning molecular profiling, clinical trial matching, and provider-facing decision support. Comparable as a deep-pocketed AI-oncology player, though it focuses more on clinical decision support than patient-facing supportive care.

9Carevive Systems
TypeDirect peer
Description

Oncology care management and patient-reported outcomes platform used by cancer centers and life sciences companies for symptom monitoring, distress screening, and value-based care documentation. Closely comparable because it serves both oncology providers and pharma trial sponsors.

TypeDirect peer
Description

AI-powered patient engagement and care navigation platform that automates outreach, symptom monitoring, and care team escalation across complex care journeys. Comparable as an enterprise health-tech platform delivering between-visit AI-driven patient communication and escalation.

Market position
Strengths4 records

Each record includes

Headline, Details, Source

Weaknesses4 records

Each record includes

Headline, Details, Source

Competitive moat6 records

Each record includes

Type, Details

Key risks6 records

Each record includes

Headline, Details, Source

Key highlights7 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers1 record

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment3 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile3 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
Yes
API detail
Has APIbool
No

Docs URL, Description

Integration1 record

Each record includes

Title, Type, Description, Source

AI capability4 records

Each record includes

Type, Description, Source

AI maturity
App detail

Has app

Feature7 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles2 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

No data
Compliance1 record

Each record includes

Name, Class, Description

Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Sanexus

Digital Health / Supportive Oncology Care Softwaresanexus.ai

Sanexus develops Asta, an agentic AI-powered digital health platform delivering adaptive supportive care, symptom monitoring, and validated PRO capture (PRO-CTCAE, EORTC QLQ-C30) for oncology patients between clinical visits. It sells B2B subscriptions to cancer centers, pharma clinical trial sponsors, and academic research institutions.

What Sanexus does

Sanexus is a privately held, founder-led digital health company headquartered in New York that has developed Asta, an agentic AI-powered platform for supportive oncology care. Asta delivers adaptive, context-aware emotional, educational, logistical, and lifestyle support to cancer patients between clinical visits; it administers validated patient-reported outcome instruments (PRO-CTCAE, EORTC QLQ-C30), tracks symptoms and quality-of-life continuously, and escalates to the clinical team when safety thresholds are met. The platform connects to electronic health records — including Epic via MyChart — through SMART on FHIR standards-based APIs, and runs on AWS infrastructure with Amazon Bedrock providing AI inference for its conversational agent. Asta operates as a Business Associate under HIPAA-compliant controls including encryption in transit, access controls, audit logging, and regular security reviews.

The company sells Asta on a B2B subscription-based SaaS model under Terms of Service effective May 26, 2026, using a direct enterprise sales motion with Request a Demo, Pilot Consultation, and Get in Touch conversion points. Pricing is not publicly disclosed and is quote-based. Three customer segments are targeted: oncology providers seeking to extend supportive care reach without adding staff; life sciences companies running oncology clinical trials that need real-time participant support, PRO capture, adherence improvement, and earlier safety signal detection; and academic research institutions and grant-funded teams (including NIH and ARPA-H applicants) needing configurable assessment protocols and longitudinal data capture for digital health intervention research. Research collaborations with Cornell Tech and the Jacobs Technion-Cornell Institute support the academic vertical.

Sanexus was founded by Malwina Lewicka, PhD (Co-Founder & CEO, health psychologist with a postdoctoral fellowship in Psycho-Oncology at Memorial Sloan Kettering Cancer Center) and Michael Federico (Co-Founder & CTO, software engineer with a BS in Computer Science from the University of Notre Dame and conversational AI experience in financial services). Stated headcount is 1–10 with only the two founders confirmed; no funding rounds, paying customers, or revenue figures are disclosed in the available sources. The company is incorporated in New York and operates as Sanexus, Inc.

Sanexus firmographics

Firmographics
Name
Sanexus
Legal name
Sanexus, Inc.
Website
https://sanexus.ai
Company type
Private
Founded year
2025
Operating status
Operating
Headcount range
1–10 employees
Short description
Sanexus develops Asta, an agentic AI-powered digital health platform delivering adaptive supportive care, symptom monitoring, and validated PRO capture (PRO-CTCAE, EORTC QLQ-C30) for oncology patients between clinical visits. It sells B2B subscriptions to cancer centers, pharma clinical trial sponsors, and academic research institutions.
Ownership category
akta.pro rank

Sanexus industry classification

Industry
Product category
Digital Health / Supportive Oncology Care Software
NAICS
Computer Systems Design Services (541512), Custom Computer Programming Services (541511), Computer Systems Design and Related Services (54151)
SIC
Services-Health Services (8000), Services-Prepackaged Software (7372), Services-Computer Integrated Systems Design (7373)
akta.pro industry
PRIMARYHLALAFAD
Oncology Remote Symptom Monitoring & Care Navigation
Healthcare & Life Sciences/Telehealth Platforms/Chronic Care & Remote Patient Monitoring (RPM) Platforms
SECONDARYHLALAGAH
Oncology Telemedicine Platforms
Healthcare & Life Sciences/Telehealth Platforms/Specialty Telemedicine Platforms (e.g., dermatology, cardiology, neurology)
SECONDARYHLAGAJAM
Clinical Trial Informatics (EDC/CTMS/eCOA/eTMF)
Healthcare & Life Sciences/Life Science Tools & Services (CRO/CDMO/Lab Services)/Life Science Software & Informatics (LIMS/ELN/Bioinformatics)
SECONDARYHLALABAJ
Patient Engagement, Education & Messaging Platforms (portal/CRM integrated)
Healthcare & Life Sciences/Telehealth Platforms/Provider-Integrated Virtual Care Platforms (Health Systems/Clinics)

Keywords

  • Supportive oncology care
  • Digital health platform
  • Patient-reported outcomes
  • Clinical trial technology
  • Conversational AI healthcare

Where Sanexus is headquartered

Location

Headquarters

HQ city
New York
HQ country
United States
HQ region
North America

Offices1 record

Markets served

Sanexus business model

Business model
GTM type
B2B
Offering type
Software
Cost components
Technology or R&D, Personnel, Infrastructure, Marketing or Sales, Operations

Revenue model

  1. Subscription-based SaaS: B2B subscription model for oncology providers, life sciences companies, and research institutions. Terms of Service references 'Subscription and Fees' section indicating recurring revenue. Pricing not publicly disclosed; likely tiered by provider size or patient volume.

Go-to-market motion1 record

Distribution channels1 record

Marketing channels1 record

Sanexus product offering

Product offering

Core offering

Sanexus develops Asta, an agentic AI-powered digital healthcare platform that delivers adaptive, real-time emotional, educational, logistical, and lifestyle support to cancer patients between clinical visits. The platform is sold as a B2B subscription to oncology providers, life sciences companies running oncology clinical trials, and academic research institutions, and combines conversational AI, validated PRO instrument assessments (PRO-CTCAE, EORTC QLQ-C30), early adverse event detection with clinical escalation, and SMART on FHIR EHR integration with Epic.

Product overview

Sanexus offers a single unified platform product called Asta — an AI-powered digital healthcare companion for supportive oncology care. The platform extends care between clinical encounters through adaptive AI-driven conversations that deliver personalized support, symptom tracking, validated assessments (PRO-CTCAE, EORTC QLQ-C30), and clinical escalation when safety thresholds are met. Asta serves three segments: oncology providers, life sciences companies (clinical trials), and research institutions.

Differentiator

Problem solved

Functional benefit

Brands

  • Asta: AI-powered supportive oncology care platform that delivers emotional, educational, logistical, and lifestyle support to cancer patients between clinical visits.

Products and services

  • Asta Agentic AI-powered digital healthcare platform for supportive oncology care. Delivers adaptive, real-time emotional, educational, logistical, and lifestyle support to cancer patients between clinical visits. Features context-aware intelligence, proactive personalized information delivery, PRO instrument integration (PRO-CTCAE, EORTC QLQ-C30), early adverse event detection with clinical escalation, and SMART on FHIR integration with Epic/MyChart. Sold as a B2B subscription to oncology providers, life sciences companies running oncology clinical trials, and academic research institutions.

Quantifiable outcome

  • 80%+ of cancer patients report unmet supportive care needs, representing the addressable market problem Asta addresses
  • +2 more outcomes

Companies that use Sanexus

Customer profile

Named customers1 record

Segments3 records

Ideal customer profiles3 records

Sanexus technology and API

Technology

Technology focussed Yes

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Integration1 record

AI capability4 records

Feature7 records

Sanexus partnerships and signals

Strategic signal

Partnerships

Three partnerships are on record, tiered core.

  • Cornell TechcoreStrategic or Co-development PartnerResearch collaboration with Cornell Tech on digital health technology development. Cornell Tech is a graduate-level institution founded by Technion-Israel Institute of Technology and Cornell University, focused on technology and entrepreneurship.
  • Jacobs Technion-Cornell InstitutecoreStrategic or Co-development PartnerAcademic partnership with the Jacobs Technion-Cornell Institute at Cornell Tech for advancing digital health interventions research and development.
  • Epic (via MyChart)coreTechnology or IntegrationEHR integration partnership enabling patients to connect Asta to their Epic MyChart account. Uses SMART on FHIR standards-based APIs to exchange demographic data, conditions, medications, lab results, vital signs, allergies, procedures, and care plans.

Scale indicators3 records

Recent moves6 records

Expansion highlights5 records

Sanexus competitors and assessment

Company assessment

Direct peers

  • Pack Health: Digital health coaching platform providing condition-specific (including oncology) one-on-one coaching and structured support between visits. Comparable in serving the same between-visit supportive care gap and selling into the same provider and pharma channels.
  • Force Therapeutics: Digital care platform delivering structured, episode-based patient engagement and PRO capture across musculoskeletal and chronic conditions. Comparable in using validated PROs, EHR integration, and enterprise sales to provider systems, though focused on orthopedics rather than oncology.
  • Jasper Health: Digital oncology platform providing personalized supportive care, symptom management, and care navigation to cancer patients between visits. Most directly comparable peer because it targets the same buyer (oncology providers), the same patient population, and the same unmet need (between-visit supportive care).
  • Navigating Cancer: Oncology patient engagement platform serving cancer centers with symptom monitoring, distress screening, and care management tools. Comparable because it sells to the same oncology provider buyers and operates in the same distress screening / supportive care gap that Asta targets.
  • Carevive Systems: Oncology care management and patient-reported outcomes platform used by cancer centers and life sciences companies for symptom monitoring, distress screening, and value-based care documentation. Closely comparable because it serves both oncology providers and pharma trial sponsors.
  • Memora Health: AI-powered patient engagement and care navigation platform that automates outreach, symptom monitoring, and care team escalation across complex care journeys. Comparable as an enterprise health-tech platform delivering between-visit AI-driven patient communication and escalation.

Emerging players

  • Hippocratic AI: Healthcare-focused LLM company building agentic AI agents for patient-facing interactions across multiple clinical use cases. Comparable as a peer in the agentic-AI-for-healthcare category, though Hippocratic targets a broader set of conditions and is better funded.
  • Vivorcare: AI-powered oncology patient support and care companion app delivering personalized education, symptom tracking, and emotional support between visits. Comparable as an AI-native oncology supportive care platform targeting similar patient/provider use cases, though likely smaller and earlier stage.

Broad incumbents

  • Flatiron Health: Roche-owned oncology technology and real-world data platform with deep penetration across US cancer centers, EHR integration, and life sciences trial services. Comparable as a much larger incumbent competing for the same oncology provider and pharma budgets, though it focuses more on data and research enablement than between-visit patient support.
  • Tempus AI: AI-powered precision medicine company with a large oncology footprint spanning molecular profiling, clinical trial matching, and provider-facing decision support. Comparable as a deep-pocketed AI-oncology player, though it focuses more on clinical decision support than patient-facing supportive care.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat6 records

Key risks6 records

Key highlights7 records

Customer concentration

Sanexus social profiles

Digital presence

Sanexus compliance and trust

Trust signal

Compliance1 record

Sanexus financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Sanexus leadership team

Management profile

Number of profiles

Profiles2 records

Sanexus funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Sanexus M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Sanexus

What does Sanexus do?

Sanexus develops Asta, an agentic AI-powered digital healthcare platform that delivers adaptive, real-time emotional, educational, logistical, and lifestyle support to cancer patients between clinical visits. The platform is sold as a B2B subscription to oncology providers, life sciences companies running oncology clinical trials, and academic research institutions, and combines conversational AI, validated PRO instrument assessments (PRO-CTCAE, EORTC QLQ-C30), early adverse event detection with clinical escalation, and SMART on FHIR EHR integration with Epic.

Is Sanexus a public or private company?

Sanexus is a private company. It is classified as founder individual operated bootstrapped and is currently operating.

When was Sanexus founded?

Sanexus was founded in 2025. It employs 1 to 10 people.

Where is Sanexus based?

Sanexus is headquartered in New York, United States, in the North America region.

How does Sanexus make money?

One revenue line is on record: subscription-based SaaS.

Who are Sanexus's main competitors?

Direct peers on record are Pack Health, Force Therapeutics, Jasper Health, Navigating Cancer, Carevive Systems and Memora Health. Emerging players are Hippocratic AI and Vivorcare. Broad incumbents are Flatiron Health and Tempus AI.

Does Sanexus have an API?

No public API is recorded for Sanexus.

What industry is Sanexus in?

Sanexus's product category is Digital Health / Supportive Oncology Care Software. Its primary akta.pro industry code is HLALAFAD, Oncology Remote Symptom Monitoring & Care Navigation, with a secondary code of HLALAGAH, Oncology Telemedicine Platforms. Its NAICS code is 541512 and its SIC code is 8000.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales